Jeff Yass’s BioLineRX BLRX Stock Holding History

Jeff Yass’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,200	Closed	-$76.4K	–	12376
2025 Q3	$76.4K	Buy	+20,200	New	+$81K	﹤0.01%	11701
2024 Q3	–	Sell	-2,763	Closed	-$63K	–	12002
2024 Q2	$63K	Sell	2,763 -1,540	-36%	-$41.3K	﹤0.01%	11312
2024 Q1	$193K	Buy	4,303 +1,188	+38%	+$59.6K	﹤0.01%	10627
2023 Q4	$196K	Buy	3,115 +540	+21%	+$33.4K	﹤0.01%	10713
2023 Q3	$187K	Buy	+2,575	New	+$173K	﹤0.01%	10303
2022 Q2	–	Sell	-415	Closed	-$28K	–	12905
2022 Q1	$28K	Sell	415 -228	-35%	-$15.9K	﹤0.01%	12527
2021 Q4	$52K	Sell	643 -1,012	-61%	-$105K	﹤0.01%	12519
2021 Q3	$181K	Buy	+1,655	New	+$196K	﹤0.01%	11606

Other funds holding BLRX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

BCV

Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jeff Yass's BLRX Position: Q2 2026 in Review

Jeff Yass opened a new position in BioLineRX (BLRX) in Q2 2026: 30,911 shares worth $95.8K. The stake represents ﹤0.01% of the portfolio and ranks #12527 among its holdings. This is a return to the name: Jeff Yass previously reported a position in BLRX as recently as Q2 2025.

Jeff Yass first reported a position in BLRX in Q1 2016 and has held it in 19 quarters since. The position peaked at $1.39M in Q1 2017. 14 funds tracked by Wall St. Rank hold BLRX as of Q2 2026.

Jeff Yass held 30,911 shares of BioLineRX worth $95.8K as of Q2 2026.
BioLineRX was a new Jeff Yass position in Q2 2026.
BioLineRX made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12527 holding.
Jeff Yass first reported a position in BioLineRX in Q1 2016 and has held it in 19 quarters since.
Jeff Yass's BioLineRX position peaked at $1.39M in Q1 2017.
14 funds tracked by Wall St. Rank held BioLineRX as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.